Alemtuzumab

An analog of geldanamycin which has potent in vivo activity and reduced toxicity has diverse anti-tumor actions promotes the degradation of HER2 and induces growth arrest and apoptosis in breast cancer cells overexpressing HER2 (IC50 = 4-72 nM).

An analog of geldanamycin which has potent in vivo activity and reduced toxicity has diverse anti-tumor actions promotes the degradation of HER2 and induces growth arrest and apoptosis in breast cancer cells overexpressing HER2 (IC50 = 4-72 nM).

An Isozyme selective Akt1/2 kinase inhibitor. In in vitro kinase assays, this shows IC|50|= 58 nM, 210 nM, and 2.12 mM for Akt1, Akt2, and Akt3. The inhibition appears to be pleckstrin homology (PH) domain-dependent and the Akt1/2 kinase inhibitor

InformationAlectinib (CH5424802) hydrochloride Alectinib (AF802, CH5424802, RO5424802, RG-7853) is a second generation oral drug that selectively inhibits the activity of anaplastic lymphoma kinase (ALK) tyrosine kinase.TargetsALK (Cell-free) 1.9

The ALG1 antibody from Proteintech is a Rabbit Polyclonal antibody to a Recombinant Protein of human ALG1. This antibody recognizes Human,Mouse,Rat antigen.

ASP-3026 inhibits anaplastic lymphoma kinase (ALK) and shows anticancer chemotherapeutic activity. Treatment with ASP-3026 lowers tumor burden in lung and intrapleural tumor models.

ASP-3026 inhibits anaplastic lymphoma kinase (ALK) and shows anticancer chemotherapeutic activity. Treatment with ASP-3026 lowers tumor burden in lung and intrapleural tumor models.

ASP-3026 inhibits anaplastic lymphoma kinase (ALK) and shows anticancer chemotherapeutic activity. Treatment with ASP-3026 lowers tumor burden in lung and intrapleural tumor models.

A potent inhibitor of ALK (IC₅₀ = 0.07 nM) that is less effective at IGF-1R and InsR (IC₅₀s = 3.

ALK-LYMPHOMA ANALYTE CONTROL CELL MICROARRAY BLOCK

The ALMS1 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human ALMS1. This antibody recognizes human antigen. The ALMS1 antibody has been validated for the following applications: IF, ELISA analysis.

InformationAlobresib (GS-5829) Alobresib (GS-5829) is a novel BET inhibitor that represents a highly effective therapeutics agent against recurrent/chemotherapy-resistant USC-overexpressing c-Myc. Alobresib (GS-5829) inhibits CLL cell proliferation